FDA Adverse Event Malfunction Summary report: N

CHEMSTRIP 10 UA

MDR report key: 2074923 · Received May 3, 2011

Report

Report Number
1823260-2011-02349
Event Type
Malfunction
Date Received
May 3, 2011
Date of Event
April 8, 2011
Report Date
July 7, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JIO
PMA / PMN Number
K896454
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Additional Manufacturer Narrative · 1

THE RESULTS OF THE INVESTIGATION WITH THE USER'S DEVICE SHOWED THAT THE VALUES WERE SLIGHTLY LOWER IN COMPARISON TO A REFERENCE METHOD. HOWEVER, THE DIFFERENCE WAS NOT POTENTIALLY CRITICAL AND WAS NOT A RISK FOR THE USER OR THE PATIENT. THE SUSPECT TRAY WAS NOT AVAILABLE FOR INVESTIGATION, THEREFORE, NO SPECIFIC ROOT CAUSE COULD BE DETERMINED. NO ADVERSE EVENTS WERE ALLEGED REGARDING THE ISSUE.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION WAS RECEIVED FROM THE USER STATING THE ASSAY INVOLVED WAS LEUKOCYTES, NOT ERYTHROCYTES AS PREVIOUSLY REPORTED ON THE INITIAL MEDWATCH. THE REPEAT RESULT ON A "CUA" WAS "++" WHICH THE USER STATED EQUALS 500 LEU/UL. THE INITIAL RESULT WAS REPORTED TO THE PHYSICIAN WHO ORDERED TESTING IN THE LABORATORY TO CONFIRM THE NEGATIVE RESULT.

Description of Event or Problem · 1

THE USER RECEIVED A QUESTIONABLE ERYTHROCYTE RESULT FOR ONE PATIENT URINE SAMPLE FROM THE URISYS 1100 URINE ANALYZER (B)(4). THE INITIAL RESULT WAS NEGATIVE. THE RESULT FROM THE LABORATORY ON A "CUA" WITH THE SAME LOT NUMBER OF CHEMSTRIPS WAS "++" AND A VISUAL READING OF THE CHEMSTRIP WAS ALSO POSITIVE. NO ADVERSE EVENTS WERE ALLEGED REGARDING THE ISSUE. THE USER STATED SHE THOUGHT THE ISSUE MAY HAVE BEEN CAUSED BY THE TRAY ON THE ANALYZER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CHEMSTRIP 10 UA METHOD, ENZYMATIC, GLUCOSE (URINARY, NON-QUANTITATIVE) JIO ROCHE DIAGNOSTICS NA 20031104

Patients

Seq Age Sex Outcome Treatment
1